Corient Capital Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$308K Buy
1,494
+220
+17% +$44.8K 0.02% 453
2022
Q2
$263K Sell
1,274
-215
-14% -$48.5K 0.02% 523
2022
Q1
$360K Buy
1,489
+513
+53% +$119K 0.02% 473
2021
Q4
$237K Buy
+976
New +$223K 0.02% 604
2021
Q3
Sell
-1,147
Closed -$237K 720
2021
Q2
$237K Buy
1,147
+28
+3% +$5.64K 0.02% 571
2021
Q1
$213K Buy
+1,119
New +$208K 0.02% 545

Other funds holding STE

Corient Capital Partners's STE Position: Q3 2022 in Review

Corient Capital Partners increased its Steris (STE) stake by 17% in Q3 2022, buying an estimated $44.8K and bringing the position to 1,494 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #453.

Corient Capital Partners first reported a position in STE in Q1 2021 and has held it in 6 quarters since. The position peaked at $360K in Q1 2022. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.

  • Corient Capital Partners held 1,494 shares of Steris worth $308K as of Q3 2022.
  • Corient Capital Partners bought 220 Steris shares in Q3 2022, an estimated $44.8K.
  • Steris made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #453 holding.
  • Corient Capital Partners first reported a position in Steris in Q1 2021 and has held it in 6 quarters since.
  • Corient Capital Partners's Steris position peaked at $360K in Q1 2022.
  • 637 funds tracked by Wall St. Rank held Steris as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.